Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Amphastar Pharmaceuticals, Inc.

http://www.amphastar.com

Latest From Amphastar Pharmaceuticals, Inc.

Start-Up Spotlight: Efemoral Begins Trial Of Peripheral Stent With Inter-Scaffold Gaps

The EFEMORAL I trial is the first-in-human study of the start-up company’s FlexStep technology in patients with symptomatic femoropopliteal artery disease.

StartUps and SMEs Start-up Spotlight

Amphastar Has First US Glucagon Rival

Amphastar has secured the first US approval for a generic version of Eli Lilly’s glucagon emergency kit.

Approvals Generic Drugs

Keeping Track: New Nucala Indication; BMS’ Ide-Cel Clears Filing Hurdle; First Applications From Telix And ADC Therapeutics

The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.

US FDA Performance Tracker Approvals

Oncimmune Expands Application Of Liquid Biopsy Auto-Antibody Technology

The company’s liquid biopsy test business is complemented by a patient-stratification service for pharmaceutical companies.

Cancer In Vitro Diagnostics
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
    • Generic Drugs
    • OTC, Consumer
    • Specialty Pharmaceuticals
    • Drug Delivery
      • Nasal
      • Pulmonary
  • Other Names / Subsidiaries
    • Amphastar France Pharmaceuticals (AFP)
    • Armstrong Pharmaceuticals, Inc.
    • International Medication Systems (IMS)
    • Nanjing Puyan Pharmaceutical Technology (ANP)
UsernamePublicRestriction

Register